Analysts: Lilly faces 'ugly' period until its pipeline produces

Back to TopCommentsE-mailPrintBookmark and Share

For Eli Lilly and Co., it's going to get worse before it gets better.

Investors smiled on the Indianapolis-based drugmaker early last week when the company unveiled experimental cancer drugs and an aggressive play for the animal health market in China. But those smiles turned to frowns after Lilly disclosed surprisingly deep cuts to its U.S. sales force.

Lilly saw its stock price rise 2.7 percent from its closing price on April 9 until a peak on April 11—just after the news of the sales force layoffs broke.

That mini rally was fueled by a report out of China on April 8 that Lilly’s Elanco Animal Health unit had invested $100 million to acquire a 20-percent stake in China Animal Healthcare Ltd., and by Lilly’s release the next morning of new details about cancer drugs in its pipeline.

But when Lilly said it would cut roughly 1,000 salespeople—which is about 30 percent of its total U.S. sales force, according to the Wall Street Journal—the company's stock dropped 1.3 percent. Lilly shares closed Friday at $57.47 apiece.

Lilly's stock price has risen 45 percent in the past year, not counting its healthy dividend, mainly on rising hopes for the success of drugs in its pipeline.

“Lilly’s got some things in the pipeline, but until they actually see the light of day, they’re like a lot of people in pharma; they have to align costs with revenue,” said Les Funtleyder, a health care investing analyst at Polliwogg in New York City. He added, “I hope Lilly gets a few new drugs and then they can hire more people.”

In fact, Lilly does plan to submit as many as three new diabetes drugs for regulatory approval this year and, if approved, those drugs could lead the company to hire 300 salespeople, according to the Wall Street Journal, which cited a person familiar with the situation. Lilly has been trying to grow its diabetes, animal health and emerging markets' business units to counteract revenue it is losing from a string of patent expirations that began in 2010.

But the only certainties at this point are that Lilly will see two of its blockbuster drugs lose their U.S. patents in roughly the next year, which will sap $4.7 billion in annual sales as patients switch to cheaper generic versions of those drugs.

Losing patent protection will be antidepressant Cymbalta, Lilly’s best-seller, and the osteoporosis drug Evista.

Wall Street analysts still expect Lilly’s overall revenue to fall from $22.6 billion last year to as low as $20 billion in 2014. Lilly’s revenue already declined from an all-time high of $24.3 billion in 2011, after the patent expirations of its blockbuster cancer drug Gemzar in 2010 and its blockbuster antipsychotic Zyprexa in 2011.

“It is going to get a little ugly for Eli Lilly in this transition period,” said David Williamson, the health care analyst for the personal finance website Motley Fool. “If you believe in Eli Lilly’s pipeline, you shouldn’t be shaken by job cuts in the near term.”

In addition to diabetes, cancer is the other big category in which Lilly is trying to bring new drugs to market. Its leading experimental cancer drug candidate right now is ramucirumab, which it is studying as a treatment for gastric and breast cancer.

On April 10, Lilly also unveiled four early-stage drugs that it is studying as treatments for melanoma, lymphoma, non-small-cell lung cancer, ovarian cancer, gastric cancer, and cancers of the bile duct and liver.


  • Generic Olanzapine
    Generic Zyprexa (Olanzapine) still a cash cow Well, Lilly did make an astounding $70 billion to date on Zyprexa and sales off-patent are still at $2 billion year.Not a bad hunk of change.-Daniel Haszard Zyprexa patient who got diabetes from it's side effect

Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ
  1. Of what value is selling alcoholic beverages to State Fair patrons when there are many families with children attending. Is this the message we want to give children attending and participating in the Fair, another venue with alooholic consumption onsite. Is this to promote beer and wine production in the state which are great for the breweries and wineries, but where does this end up 10-15 years from now, lots more drinkers for the alcoholic contents. If these drinks are so important, why not remove the alcohol content and the flavor and drink itself similar to soft drinks would be the novelty, not the alcoholic content and its affects on the drinker. There is no social or material benefit from drinking alcoholic beverages, mostly people want to get slightly or highly drunk.

  2. I did;nt know anyone in Indiana could count- WHY did they NOT SAY just HOW this would be enforced? Because it WON;T! NOW- with that said- BIG BROTHER is ALIVE in this Article-why take any comment if it won't appease YOU PEOPLE- that's NOT American- with EVERYTHING you indicated is NOT said-I can see WHY it say's o Comments- YOU are COMMIES- BIG BROTHER and most likely- voted for Obama!

  3. In Europe there are schools for hairdressing but you don't get a license afterwards but you are required to assist in turkey and Italy its 7 years in japan it's 10 years England 2 so these people who assist know how to do hair their not just anybody and if your an owner and you hire someone with no experience then ur an idiot I've known stylist from different countries with no license but they are professional clean and safe they have no license but they have experience a license doesn't mean anything look at all the bad hairdressers in the world that have fried peoples hair okay but they have a license doesn't make them a professional at their job I think they should get rid of it because stateboard robs stylist and owners and they fine you for the dumbest f***ing things oh ur license isn't displayed 100$ oh ur wearing open toe shoes fine, oh there's ONE HAIR IN UR BRUSH that's a fine it's like really? So I think they need to go or ease up on their regulations because their too strict

  4. Exciting times in Carmel.

  5. Twenty years ago when we moved to Indy I was a stay at home mom and knew not very many people.WIBC was my family and friends for the most part. It was informative, civil, and humerous with Dave the KING. Terri, Jeff, Stever, Big Joe, Matt, Pat and Crumie. I loved them all, and they seemed to love each other. I didn't mind Greg Garrison, but I was not a Rush fan. NOW I can't stand Chicks and all their giggly opinions. Tony Katz is to abrasive that early in the morning(or really any time). I will tune in on Saturday morning for the usual fun and priceless information from Pat and Crumie, mornings it will be 90.1